(Press-News.org) ATLANTA — Eating a plant-based diet consisting of fruits, vegetables, nuts and legumes can help prevent and reverse heart disease in rats that have high blood pressure, according to a study published by researchers in the Institute for Biomedical Sciences at Georgia State University.
The basic research study, published in the Journal of the American Heart Association, tested whether coronary microvascular dysfunction (CMD), a type of heart disease that occurs when there’s damage to the tiny blood vessels that regulate blood flow to heart tissue, could be reduced in rats with hypertension. The study also examined underlying mechanisms of CMD.
Hypertension is a major risk factor for CMD, which can lead to frequent chest pain, hospitalizations, heart failure and deaths. Uniquely, CMD afflicts women more severely than men, and women have higher rates of hospitalizations compared to men after diagnosis.
Therapeutic strategies for CMD are only moderately effective, and patients continue to have poor outcomes. Thus, new treatment approaches are urgently needed. This is one of the first studies to look at the role of diet in treating CMD, and the research team investigated the effects of a plant-based diet.
“We found that a plant-based diet both prevented the development of CMD and reversed established CMD in hypertensive rats, which translates well to the clinical setting,” said Rami S. Najjar, corresponding author of the study, a postdoctoral fellow in the Institute for Biomedical Sciences at Georgia State when the study was conducted and now a postdoctoral fellow at Emory University School of Medicine in the Division of Cardiology.
“Interestingly, the beneficial effects of the plant-based diet in CMD occurred despite the persistence of hypertension, showing that the diet was having a targeted effect on the small blood vessels of the heart,” Najjar explained. “We believe this effect occurred due to improved function of blood vessel cells, counteracting the damaging effects of hypertension. When these cells are damaged, blood vessels in the heart contract and blood cannot flow well, the cause of chest pain in humans with CMD. However, the plant-based diet rescued the function of these cells, allowing blood vessels to dilate normally again. This is one of the first studies to show that diet can treat CMD. These exciting results support clinical trials to test plant-based diets in human CMD, and we hope to do this soon.”
This study fed female spontaneously hypertensive rats for six months either a control, refined diet, absent in plant foods, or a plant-based diet, which comprised 28 percent fruits, vegetables, nuts and legumes. Importantly, both diets were matched for all nutrients, so the only known difference was the high antioxidant content of the plant-based diet. If a human ate this diet, it would contain one cup of black beans, one large red bell pepper, 1 ½ cups of Brussels sprouts, two lemons, one medium sweet potato, 1 ½ cups of walnuts and one cup of blueberries each day. After six months, a subgroup of rats eating the control diet was switched to the plant-based diet to treat CMD after it was established.
CMD was assessed by measuring coronary flow reserve, an approach used in the clinic. Researchers also used Georgia State’s recently established Advanced Translational Imaging Facility, using cardiac MRI to look at blood flow of the heart muscle. In addition, investigators isolated blood vessel cells from the heart to look at their function and examined markers of damage in heart tissue.
Additional authors of the study include Yanling Wang, Vu Ngo, Juan P. Tejada and Andrew T. Gewirtz of the Institute for Biomedical Sciences at Georgia State; Nedumangalam Hekmatyar of the Advanced Translational Imaging Facility at Georgia State; Hannah L. Lail, Jessica P. Danh, Desiree Wanders and Rafaela G. Feresin of the Department of Nutrition and the Department of Chemistry at Georgia State; and Puja K. Mehta of Emory University School of Medicine.
The study was funded by Najjar’s Agriculture and Food Research Initiative postdoctoral grant from the U.S. Department of Agriculture’s National Institute of Food and Agriculture.
To read the study, visit https://www.ahajournals.org/doi/full/10.1161/JAHA.125.045515.
END
Study: Plant-based diet can prevent, reverse form of heart disease in animals with hypertension
2025-11-12
ELSE PRESS RELEASES FROM THIS DATE:
Lower LRIG1 expression linked to aggressive gliomas
2025-11-12
“Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas.”
BUFFALO, NY – November 12, 2025 – A new research paper was published in Oncotarget (Volume 16) on November 6, 2025, titled “LRIG1-3 in gliomas: LRIG1 protein expression decreased in higher grade gliomas.”
In this study by Marlene Happe, Saskia Kuhl, Lukas Görtz, Roland Goldbrunner and Marco Timmer, from the University of Cologne, researchers found that the LRIG1 protein, which may help suppress tumors, is present at lower levels in more aggressive gliomas, a type of brain tumor. The findings ...
National consortium project led by TU Delft receives huge grant from NWO to build world's largest research digital twins for energy systems
2025-11-12
A cutting-edge consortium project called Understanding large and cOmplex Power sYstems (UTOPYS) will enable researchers to build the world’s largest research cluster for real-time energy system studies. The project is led by Principal Investigator Prof. Peter Palensky of TU Delft, and is comprised of eight Dutch research organisations, and SURF - the IT cooperative of education and research. It has been awarded a huge grant of 16.5 million euros through the Large-Scale Research Infrastructure ...
Intranasal oxytocin and physical intimacy for dermatological wound healing and neuroendocrine stress
2025-11-12
About The Study: This study found that intimate physical contact can reduce cortisol responses and, along with oxytocin administration, promote wound healing. These findings provide a foundation for future interventions that integrate relationship dynamics and neurohormonal modulation to improve health and recovery from illness.
Corresponding Authors: To contact the corresponding authors, email Beate Ditzen, PhD (b.ditzen@psychologie.uzh.ch) and Ekaterina Schneider, PhD (e.schneider@psychologie.uzh.ch).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2025.3705)
Editor’s ...
JMIR Publications partners with Signals to strengthen research integrity across its portfolio
2025-11-12
(Toronto, November 12, 2025) JMIR Publications is pleased to announce an agreement with Signals Manuscript Checks to leverage their tool across their entire portfolio.
JMIR Publications, a leading publisher in digital medicine, health technology and sciences, has begun evaluating article submissions with Signals Manuscript Checks — a tool that provides automated and transparent evaluations of manuscripts to identify research integrity issues, and enables AI-supported investigations of manuscripts through Sleuth AI, Signals’ AI-powered research integrity assistant.
With Signals Manuscript Checks, JMIR Publications aims to increase the efficiency and ...
Scientists make dark exciton states shine, unlocking new frontiers for nanotechnology
2025-11-12
New York, November 12, 2025 — A research team at the City University of New York and the University of Texas at Austin has discovered a way to make previously hidden states of light, known as dark excitons, shine brightly, and control their emission at the nanoscale. Their findings, published today in Nature Photonics, open the door to faster, smaller, and more energy-efficient technologies.
Dark excitons are exotic light-matter states in atomically thin semiconductors that typically remain invisible because they emit light very weakly. These states, however, are highly ...
Glenn Foundation for Medical Research grant programs provide $2.25 million in support for postdoctoral investigators and junior faculty
2025-11-12
NEW YORK, NY and SANTA BARBARA, CA — The American Federation for Aging Research (AFAR) and the Glenn Foundation for Medical Research (GFMR) are pleased to announce the 2025 recipients of the Grants for Junior Faculty, Postdoctoral Fellowships in Aging Research, and Postdoctoral Fellowship Continuation Awards. Selected through rigorous review processes led by scientific committees of esteemed leaders in aging ...
The mechanisms behind thrombocytopenia in patients with portal hypertension and chronic liver disease
2025-11-12
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal hypertension (PH) being a primary driver of disease progression and decompensation. A hallmark of this condition is thrombocytopenia, defined as a platelet count ≤150,000/μL, which is present in 64–77% of cirrhotic patients. This hematological abnormality is not merely a laboratory finding but a distinctive sign of PH and a component of prognostic risk scores for adverse liver outcomes. This essay elucidates the multifactorial ...
SwRI uses machine learning to calibrate emissions control systems faster, more efficiently
2025-11-12
SAN ANTONIO — November 12, 2025 — Southwest Research Institute (SwRI) has developed a method to automate the calibration of heavy-duty diesel truck emissions control systems using machine learning and algorithm-based optimization. The latest diesel aftertreatment systems often take weeks to calibrate. SwRI’s new method can calibrate them in as little as two hours.
“Manually calibrating selective catalytic reduction (SCR) systems is labor-intensive, often taking six or more weeks of testing and work,” said Venkata Chundru, senior research engineer in SwRI’s Advanced ...
Blood test offers hope for more effective ovarian cancer treatment
2025-11-12
More than 300,000 women are diagnosed with ovarian cancer globally each year.
The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney NHMRC Clinical Trials Centre, RMIT University and WEHI, and coordinated by the Australia New Zealand Gynaecological Oncology Group (ANZGOG).
The Phase II trial tested strategies for priming the immune system to enhance the effectiveness of PARP inhibitor therapy, which stops cancer cells from repairing their own damaged DNA by blocking the PARP enzyme.
It was during this trial that a new companion blood test for women with ovarian cancer was also ...
Pain during a C-section? New study challenges fears about general anesthesia
2025-11-12
PHILADELPHIA—Regional anesthesia—typically with a spinal or epidural block—has long been favored for cesarean births due in part to concerns about the effects that general anesthesia may have on newborns during labor and delivery. Powerful societal pressures also push the idea that mothers need to be awake during delivery to witness the first cry and capture the ‘perfect’ birth moment. But for some women who undergo a cesarean birth, the pain can become excruciating, even after they received a spinal or epidural block. Now, new research from a team at the Perelman School of Medicine at the ...